Black men are approximately two times more likely to develop and die from advanced prostate cancer compared to white men. Despite these disparities, Black men comprise less than three percent of therapeutic clinical trials in advanced prostate cancer. Disparities in whom cancer clinical trials serve is a long-standing problem that is likely further widening the treatment gap. To date, innovation in novel recruitment strategies of racially/ethnically diverse populations has been limited. We believe that the Internet used in combination with rapid case reporting from population-based cancer registries can be a feasible approach to provide patient-centered information about prostate cancer clinical trials to underrepresented populations.